loratadine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

loratadine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ackland, MJ; Alex, AA; de Groot, MJ; Horne, VA; Jones, BC	1

Other Studies

1 other study(ies) available for loratadine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6. Journal of medicinal chemistry, 1999, Oct-07, Volume: 42, Issue:20 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Betaxolol; Cytochrome P-450 CYP2D6; Dealkylation; Fluoxetine; Loratadine; Models, Molecular; Pharmaceutical Preparations; Procainamide; Ritonavir; Substrate Specificity; Sumatriptan	1999

Article

Year

A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6.

Journal of medicinal chemistry, 1999, Oct-07, Volume: 42, Issue:20

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Betaxolol; Cytochrome P-450 CYP2D6; Dealkylation; Fluoxetine; Loratadine; Models, Molecular; Pharmaceutical Preparations; Procainamide; Ritonavir; Substrate Specificity; Sumatriptan

1999